WWP
BIIB icon

WR Wealth Planners’s Biogen BIIB Stock Holding History

WR Wealth Planners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.22K Hold
8
– – ﹤0.01% 909
2024
Q3 		$1.55K Sell
8
-372
-98% -$77.8K ﹤0.01% 932
2024
Q2 		$88.1K Buy
380
+11
+3% +$2.39K 0.03% 261
2024
Q1 		$79.6K Buy
+369
New +$86.4K 0.02% 279
2023
Q4 		– Sell
-365
Closed -$93.8K – 246
2023
Q3 		$93.8K Buy
+365
New +$97.6K 0.04% 248

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WR Wealth Planners's BIIB Position: Q4 2024 in Review

WR Wealth Planners held its Biogen (BIIB) position steady in Q4 2024 at 8 shares worth $1.22K. The position accounts for ﹤0.01% of the portfolio, ranked #909.

WR Wealth Planners first reported a position in BIIB in Q3 2023 and has held it in 5 quarters since. The position peaked at $93.8K in Q3 2023. 875 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • WR Wealth Planners held 8 shares of Biogen worth $1.22K as of Q4 2024.
  • WR Wealth Planners left its Biogen share count unchanged in Q4 2024.
  • Biogen made up ﹤0.01% of WR Wealth Planners's portfolio in Q4 2024, its #909 holding.
  • WR Wealth Planners first reported a position in Biogen in Q3 2023 and has held it in 5 quarters since.
  • WR Wealth Planners's Biogen position peaked at $93.8K in Q3 2023.
  • 875 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on WR Wealth Planners's 13F filing for Q4 2024, filed 5 Feb 2025.